Verition Fund Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,717
Closed -$48.5K 3446
2024
Q2
$48.5K Buy
+30,717
New +$44.6K ﹤0.01% 2801
2018
Q2
Sell
-14,556
Closed -$223K 1259
2018
Q1
$223K Buy
+14,556
New +$208K 0.02% 955
2017
Q1
Sell
-12,425
Closed -$299K 1404
2016
Q4
$299K Buy
+12,425
New +$346K 0.03% 832
2016
Q2
Sell
-13,833
Closed -$465K 1010
2016
Q1
$465K Buy
+13,833
New +$436K 0.08% 345

Other funds holding PGEN

Verition Fund Management's PGEN Position: Q3 2024 in Review

Verition Fund Management sold out of Precigen (PGEN) in Q3 2024, closing a stake of 30,717 shares — an estimated $48.5K sold.

Verition Fund Management first reported a position in PGEN in Q1 2016 and held it in 4 quarters. The position peaked at $465K in Q1 2016. 127 funds tracked by Wall St. Rank hold PGEN as of Q3 2024.

  • Verition Fund Management reported no remaining Precigen position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 30,717 Precigen shares in Q3 2024, an estimated $48.5K.
  • Verition Fund Management first reported a position in Precigen in Q1 2016 and held it in 4 quarters.
  • Verition Fund Management's Precigen position peaked at $465K in Q1 2016.
  • 127 funds tracked by Wall St. Rank held Precigen as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.